ZDHHC12-DT: A Drug Target / Disease Biomarker (G100506100)

Target Name: ZDHHC12-DT

NCBI ID: G100506100

ZDHHC12-DT

Other Name(s): ZDHHC12 divergent transcript

ZDHHC12-DT: A Drug Target / Disease Biomarker

ZDHHC12-DT is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the Zinc Finger Nucleases (ZFN) family, which are a group of non-coding RNAs that play a critical role in post-transcriptional gene regulation. ZDHHC12-DT is unique among its family members due to its ability to interact with small molecules, such as drugs, and its potential as a drug target.

The ZFN family of RNA-protein hybrids consists of more than 200 members, each characterized by a specific ZNF/DISP domain and a unique N-terminus. ZFNs are involved in a wide range of cellular processes, including chromatin remodeling, transcriptional regulation, and stress response. Many of these ZFNs are also potential drug targets, due to their ability to modulate cellular behavior in response to small molecules.

ZDHHC12-DT is a member of the ZFN-12 family, which is characterized by a specific ZNF/DISP domain and a unique N-terminus. ZDHHC12-DT is expressed in various tissues of the body, including the brain, heart, and liver, and has been shown to play a role in a variety of cellular processes.

One of the unique features of ZDHHC12-DT is its ability to interact with small molecules, such as drugs. This interaction allows ZDHHC12-DT to serve as a drug target, with potential applications in a wide range of therapeutic areas. For example, ZDHHC12-DT has been shown to play a role in the regulation of cellular stress responses, which could make it a potential target for drugs that are designed to improve cellular stress resilience.

In addition to its potential as a drug target, ZDHHC12-DT is also of interest as a biomarker. Its expression has been shown to be regulated in response to a wide range of small molecules, including drugs. This regulation is consistent with its function as a drug target, as drugs can modulate cellular behavior in response to these small molecules. By using ZDHHC12-DT as a biomarker, researchers may be able to study the effects of drugs on cellular behavior and determine whether these effects are due to their ability to interact with ZDHHC12-DT.

In conclusion, ZDHHC12-DT is a unique protein that is characterized by its ability to interact with small molecules and its potential as a drug target. Its expression is regulated in response to a wide range of small molecules, including drugs, which suggests that it may be a valuable biomarker for the study of cellular behavior. Further research is needed to determine the full extent of ZDHHC12-DT's potential as a drug target and its utility as a biomarker.

Protein Name: ZDHHC12 Divergent Transcript

The "ZDHHC12-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZDHHC12-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets